Aurobindo Pharma Limited — Others, 20-08-2025: Rumour Verification - Regulation 30(11)

Aurobindo Pharma has clarified a media report regarding a potential $5.5 billion acquisition of Zentiva. The company stated that while it regularly explores strategic opportunities, including acquisitions to enhance shareholder value, its Board has made no binding agreement or definitive decision on this specific transaction. Therefore, the news is premature and should not be relied upon. The company assured it would promptly issue necessary announcements for any definitive developments.